Name: Immunotherapies in Solid Tumors: A Team Medicine Approach (en Inglés)
SKU: 66291368
Price: 167410.00 CLP
Availability: InStock
Author: Salgia, Ravi; Kulkarni, Prakash
ISBN: 9783031972416

portada Immunotherapies in Solid Tumors: A Team Medicine Approach (en Inglés)

Immunotherapies in Solid Tumors: A Team Medicine Approach (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Salgia, Ravi; Kulkarni, Prakash

Idioma

Inglés

N° páginas

332

Encuadernación

Tapa Dura

Dimensiones

22.6x15.2x2.3 cm

ISBN13

9783031972416

Immunotherapies in Solid Tumors: A Team Medicine Approach (en Inglés)

Salgia, Ravi; Kulkarni, Prakash (Autor) · Springer · Tapa Dura

Libro Nuevo Importado

Envío: 22 a 26 días háb.

$ 304.390$ 167.410

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 167.410

Llega entre el 21 Oct y el 27 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Immunotherapies in Solid Tumors: A Team Medicine Approach (en Inglés)"

This book covers state-of-the-art immunotherapeutic modalities also discusses how phenotypic plasticity of cancer cells plays a crucial role in the emergence of immune resistance. Targeting both medical oncologists and basic cancer researchers, this book fills a crucial gap by emphasizing the importance of a team medicine approach that integrates major medical centers and the clinical practices in their network. The goals are to educate professionals on the importance of an integrated approach to enhance the quality of research and patient care in oncology. This work stands out as an essential resource to the community challenged with integrating basic and translational research, along with clinical medicine in academic centers and their clinical networks worldwide. Authored by world-renowned experts in the field, this book fills a significant gap in the literature by focusing specifically on integrating the experience and expertise of basic scientists and clinicians both in academic centers and the oncology hospitals in their clinical network.